Navigation Links
Agendia Appoints VP of Business Development

HUNTINGTON BEACH, California and AMSTERDAM, The Netherlands, February 11 /PRNewswire/ -- Agendia, a world leader in molecular cancer diagnostics, today announced the appointment of Alan B. Carter as the company's new Vice President of Global Business Development.

"As we continue to grow as a global company, Alan's appointment furthers one of our primary aims," commented Dr. Bernhard Sixt, Ph.D., President and Chief Executive Officer. "His extensive business development expertise will strengthen our ongoing programs and pipeline projects and also allows us to capitalize on our genomics platform in close collaboration with biotechnology and pharmaceutical partners. With Alan's involvement, Agendia will continue to play a central role in making targeted therapies one of the cornerstones of personalized medicine."

Mr. Carter brings 25 years of business development, sales and marketing experience from a number of top tier life sciences companies such as BioTrove, Celera, Applied Biosystems and Perkin Elmer. At Agendia, Mr. Carter will assume responsibility for strategic business opportunities to build on the current success of Agendia's molecular diagnostics portfolio. This products suite includes MammaPrint(R), the only FDA approved test for rapidly and accurately diagnosing therapeutic options for breast cancer patients. Additionally, he will play an important role in forging Agendia's strategic alliances with pharmaceutical and biotech companies to accelerate the use of molecular diagnostics in drug development, companion diagnostics and safety testing programs.

About Agendia

Agendia is at the forefront of the personalized medicine revolution, striving to bring more effective, individualized treatments within reach of patients. Building on a cutting edge genomics platform for tumor gene expression profiling, the company's tests aim to help physicians more accurately tailor cancer treatments. The company markets four products, with several new genomic tests under development. In addition, Agendia collaborates with pharmaceutical companies to develop highly effective personalized drugs in the area of oncology. Agendia was awarded the 2008 North American Oncology Clinical Diagnostics Healthcare Innovation Award by Frost & Sullivan. Agendia is based in Huntington Beach, California, and in Amsterdam, The Netherlands.

For more information please visit

SOURCE Agendia B.V.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Agendia BV Appoints Mr. Hessel Lindenbergh as Chairman of its Supervisory Board
2. Agendia Joins the Personalized Medicine Coalition (PMC)
3. Agendia Acquires Rights to the Discovery of a Major Drug Resistance Mechanism in Breast Cancer Potentially Leading to a Herceptin(R) Sensitivity Test
4. Agendia BV Announces That its Chief Research Officer Laura van t Veer has Received a 2007 Breast Cancer Research Foundation Award
5. Agendia BV Appoints Clinical and Scientific Advisory Board
6. Agendia and Agilent Announce Plans to Jointly Develop New Diagnostic Tests, Extend Supply Agreement
7. Agendias MammaPrint(R) Receives Prestigious Award From Dutch Innovation Platform
8. Agendia and Ferrer Announce Exclusive Agreement for Sales of Cancer Diagnostic Services in Four Major European Markets
9. Agendia Appoints New Chief Financial Officer
10. Agendias Breast Cancer Test MammaPrint(R) Standard of Care at Netherlands Cancer Institute - AVL
11. BioVex Appoints Dr. Thaddeus Pullano as VP, Quality Assurance
Post Your Comments:
(Date:10/9/2015)... On October 8, the Honorable Doris O. ... recognizing the third annual International Plasma Awareness Week (IPAW), ... the Plasma Protein Therapeutics Association (PPTA) and ... , Raise global awareness about plasma donation , ... improving lives , Increase understanding about lifesaving plasma ...
(Date:10/9/2015)... 9, 2015  Pulmatrix, Inc., (NASDAQ: PULM ) will ... conferences. th Annual BIO Investor Forum ... pm EDT). --> th Annual BIO ... PDT (2:00 pm EDT). --> Pulmatrix will ... Stock Conference on Thursday, October 15, 2015 at 8:30 am ...
(Date:10/8/2015)... Fla. , Oct. 8, 2015   Intrexon ... synthetic biology, today announced the appointment of Joseph ... Environment Sector, succeeding Nir Nimrodi who continues ... Vaillancourt will direct Intrexon,s endeavors to generate sustainable, biologically ... America , where he held a variety of ...
(Date:10/8/2015)... N.C. and WAYNE, Pa. ... management and technology consulting firm, has announced the call ... Pennsylvania , majoring in a life ... over a two-year period. In addition, the selected Clarkston ... through mentoring with Clarkston Consulting and participation in Pennsylvania ...
Breaking Biology Technology:
(Date:10/8/2015)... , Oct. 8, 2015 Synaptics ... human interface solutions, announced today that it will ... fiscal 2016 on Thursday, October 22, 2015, after ... a corresponding conference call for analysts and investors ... which management may discuss forward-looking information.    ...
(Date:10/6/2015)... LAKE CITY , Oct. 6, 2015 ... company, announced today that it has signed a contract ... monitoring services across the full range of sentences under ... Group,s President of the Americas. "This contract with the ... region of the US and advances our position as ...
(Date:9/30/2015)...  With nearly 300,000 Americans living with spinal cord ... to reach 12,500 annually, the role of Independent Living ... Independent Living (SCRS-IL) is increasingly important. SCRS-IL is ... opening doors to independence for individuals with SCIs ... assistive technology services and education. "In serving ...
Breaking Biology News(10 mins):